Gary J. Nabel

Active 1981–2025

239
Papers
58,700
Citations
138
h-index
238
i10-index

Citations

Citations per year for Gary J. Nabel1981: 13 citations1982: 20 citations1983: 10 citations1984: 20 citations1985: 47 citations1986: 60 citations1987: 58 citations1988: 105 citations1989: 128 citations1990: 182 citations1991: 152 citations1992: 235 citations1993: 322 citations1994: 308 citations1995: 336 citations1996: 317 citations1997: 363 citations1998: 392 citations1999: 443 citations2000: 384 citations2001: 348 citations2002: 320 citations2003: 382 citations2004: 362 citations2005: 461 citations2006: 477 citations2007: 425 citations2008: 373 citations2009: 324 citations2010: 465 citations2011: 505 citations2012: 520 citations2013: 662 citations2014: 654 citations2015: 700 citations2016: 593 citations2017: 489 citations2018: 453 citations2019: 1,280 citations2020: 1,620 citations2021: 1,298 citations2022: 887 citations2023: 677 citations2024: 984 citations2025: 458 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,688 citing papers, 41.9% of this breakdownChina: 1,144 citing papers, 6.2% of this breakdownUnited Kingdom: 1,071 citing papers, 5.8% of this breakdownGermany: 873 citing papers, 4.8% of this breakdownFrance: 709 citing papers, 3.9% of this breakdownCanada: 635 citing papers, 3.5% of this breakdownJapan: 545 citing papers, 3% of this breakdownNetherlands: 460 citing papers, 2.5% of this breakdownItaly: 451 citing papers, 2.5% of this breakdownAustralia: 396 citing papers, 2.1% of this breakdownSwitzerland: 365 citing papers, 2% of this breakdownIndia: 306 citing papers, 1.7% of this breakdown
0%41.9%Other 20.1%

Fields

  • Medicine42.8%
  • Immunology and Microbiology26.6%
  • Biochemistry, Genetics and Molecular Biology26.3%
  • Agricultural and Biological Sciences0.7%
  • Environmental Science0.6%
  • Neuroscience0.5%
  • Other2.5%

Topics

  • HIV Research and Treatment6.5%
  • Immune Cell Function and Interaction4.2%
  • SARS-CoV-2 and COVID-19 Research3.8%
  • Immunotherapy and Immune Responses3.2%
  • Monoclonal and Polyclonal Antibodies Research3%
  • Viral Infections and Outbreaks Research2.7%
  • Other76.6%

Coauthors

All papers

Open in search
  1. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

    Authors: , , , , , , , , , - Nature 2013 cited by 917

  2. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qunyan Yu, Yuan Zhang, Gang Zheng, Joanne Lager, Gary J. Nabel, Uğur Şahin, Dmitri Wiederschain - Science Translational Medicine 2021 cited by 206

  3. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 2010 cited by 1,802

  4. Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fangxian Sun, Marielle Chiron, Srinivas Rao, Katarina Radošević, Zhiyong Yang, Gary J. Nabel - Nature Cancer 2019 cited by 250

  5. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

    Authors: , , , , , , , , , , , , , , , , , - Science 2010 cited by 1,177

  6. Next-generation influenza vaccines: opportunities and challenges

    Authors: , , , , , - Nature Reviews Drug Discovery 2020 cited by 334

  7. Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

    Authors: , , , , , , , , , , , , , , , , - Cell 2015 cited by 391

  8. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 724

  9. A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 152

  10. A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice

    Authors: , , , , , , , , , , - Science Translational Medicine 2022 cited by 100

  11. Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells

    Authors: , , , , , , , , , , , , , , , , , - Immunity 2019 cited by 182

  12. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 585

  13. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

    Authors: , , , , , , , , , , - Nature Medicine 2010 cited by 495

  14. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 400

  15. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain

    Authors: , , , , , , , , , , , , , , , , , - Science Immunology 2020 cited by 117

  16. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xuejun Chen, Florence Kaltovich, Kevin O. Saunders, Judy Stein, Nicole A. Doria‐Rose, Richard Schwartz, Alejandro B. Balazs, David Baltimore, Gary J. Nabel, Richard A. Koup, Barney S. Graham, Julie E. Ledgerwood, John R. Mascola, the VRC 603 Study Team, Charla Andrews, Anita Arthur, Seemal F. Awan, Allison Beck, Eugeania Burch, Maria Claudia Burgos Florez, Nina M. Berkowitz, Eli Boritz, Kevin Carlton, Cora Trelles Cartagena, Christina Carter, Grace Chen, Pamela Costner, Jennifer Cunningham, Daniel C. Douek, Aba M. Eshun, Catina Evans, Renunda Hicks, Katherine V. Houser, Justine Jones, Brenda Larkin, Lam Le, Floreliz Mendoza, Stephen A. Migueles, John Misasi, Thuy A. Nguyen, Abidemi Ola, Karen Parker, Iris Pittman, La’ Shawn Requilman, Ro Shauna Rothwell, Gretchen L. Schieber, Jamie Saunders, Sandra Sitar, Colin Tran, Olga Trofymenko, Olga Vasilenko, Sana Waheed, Lingshu Wang, Xiaolin Wang, William Whalen, Pernell Williams, Richard L. C. Wu, Kathy Zephir - Nature Medicine 2022 cited by 94

  17. Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Shapiro, Gary J. Nabel, John R. Mascola, Peter D. Kwong - Immunity 2013 cited by 387

  18. Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages

    Authors: , , , , , , , , , , , , , , , - Journal of Virology 2014 cited by 258

  19. Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

    Authors: , , , - Science Translational Medicine 2011 cited by 386

  20. Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus

    Authors: , , , , , , , , , , , , , , - PLoS Pathogens 2013 cited by 308

  21. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel E. Sam, Barton F. Haynes, Dennis R. Burton, Wayne C. Koff, Laura M. Walker, Sanjay Phogat, Richard T. Wyatt, Jared Orwenyo, Lai‐Xi Wang, James Arthos, Carole A. Bewley, John R. Mascola, Gary J. Nabel, William R. Schief, Andrew B. Ward, Ian A. Wilson, Peter D. Kwong - Nature 2011 cited by 853

  22. Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James C. Mullikin, Lawrence Shapiro, Richard A. Koup, Barney S. Graham, Martha Nason, Mark Connors, Barton F. Haynes, Srinivas S. Rao, Mario Roederer, Peter D. Kwong, John R. Mascola, Gary J. Nabel - Journal of Virology 2014 cited by 291

  23. Immunization by Avian H5 Influenza Hemagglutinin Mutants with Altered Receptor Binding Specificity

    Authors: , , , , , , - Science 2007 cited by 257

  24. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Roederer, Mark Connors, Richard A. Koup, Peter D. Kwong, Zhiyong Yang, John R. Mascola, Gary J. Nabel - Science 2017 cited by 271